Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study

被引:27
|
作者
Koo, Bo Kyung [1 ,2 ]
Chung, Woo-Young [1 ,3 ]
Moon, Min Kyong [1 ,2 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Dept Internal Med, Div Endocrinol, Boramae Med Ctr, 20 Boramaero 5 Gil, Seoul 07061, South Korea
[3] Seoul Natl Univ, Dept Internal Med, Div Cardiol, Boramae Med Ctr, Seoul, South Korea
关键词
Reactive hyperemia; Endothelial function; Type; 2; diabetes; Ischemic heart disease; Nonfatal stroke; Heart failure; Chronic kidney disease; REACTIVE HYPEREMIC INDEX; RISK-FACTORS; VASCULAR FUNCTION; NATIONAL-HEALTH; BLOOD-PRESSURE; HEART-DISEASE; MORTALITY; ASSOCIATION; POPULATION; TONOMETRY;
D O I
10.1186/s12933-020-01062-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundReactive hyperemia-peripheral arterial tonometry (RH-PAT) is a noninvasive and simple test for evaluating the endothelial function. There has been sparse evidence on the usefulness of the RH-PAT index (RHI) in predicting future cardiovascular diseases among diabetic patients.MethodsAsymptomatic diabetic patients with albuminuria were selected; their medical history and laboratory findings were evaluated every 3 to 4 months, respectively. The primary outcome was a composite of three-point major adverse cardiovascular events (3-point MACE): death from cardiovascular causes, acute coronary events, or nonfatal stroke. On the contrary, secondary outcomes included a composite of 3-point MACE, hospitalization for heart failure, or chronic kidney disease (CKD) progression. RHI was measured using the Endo-PAT2000 at the baseline. RHI<1.67 was considered to indicate peripheral endothelial dysfunction (PED).ResultsIn total, 149 subjects were included (mean age, 61.89.2 years; duration of diabetes was 12 years). During the follow-up period (median, 49.7 months), of the 149 subjects, primary outcomes were detected in 12 (1 [2.3%] and 11 [10.5%] of those without and with PED, respectively). The presence of PED in baseline measurements significantly increased both primary and secondary outcomes, following adjustment for age, sex, hypertension, glycated hemoglobin, low-density lipoprotein cholesterol, triglyceride, systolic blood pressure, baseline estimated glomerular filtration rate, overt proteinuria, duration of diabetes, premedical history of ischemic events, anti-platelet agents, and smoking history (hazard ratio [HR]: 10.95; 95% confidence interval CI 1.00-119.91 for the primary outcome; HR, 4.12; 95% CI 1.37-12.41 for secondary outcome). In addition, PED could predict secondary outcomes independent of the risk score according to the American College of Cardiology/American Heart Association (HR: 3.24; 95% CI 1.14-9.17).Conclusions p id=Par PED can independently predict future cardiovascular events among diabetic patients with albuminuria.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study
    Moreno-Ajona, David
    Irimia, Pablo
    Rodriguez, Jose Antonio
    Garcia-Velloso, Maria Jose
    Lopez-Fidalgo, Jesus
    Fernandez-Alonso, Leopoldo
    Grochowitz, Lukasz
    Munoz, Roberto
    Dominguez, Pablo
    Gallego-Cullere, Jaime
    Martinez-Vila, Eduardo
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [12] Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes
    Theilade, S.
    Lajer, M.
    Jorsal, A.
    Tarnow, L.
    Parving, H. -H.
    Rossing, P.
    DIABETIC MEDICINE, 2012, 29 (08) : 990 - 994
  • [13] Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events
    Rubinshtein, Ronen
    Kuvin, Jeffrey T.
    Soffler, Morgan
    Lennon, Ryan J.
    Lavi, Shahar
    Nelson, Rebecca E.
    Pumper, Geralyn M.
    Lerman, Lilach O.
    Lerman, Amir
    EUROPEAN HEART JOURNAL, 2010, 31 (09) : 1142 - 1148
  • [14] Spousal metabolic risk factors and future cardiovascular events: A prospective cohort study
    Ramezankhani, Azra
    Guity, Kamran
    Azizi, Fereidoun
    Hadaegh, Farzad
    ATHEROSCLEROSIS, 2020, 298 : 36 - 41
  • [15] Ambulatory pulse pressure predicts cardiovascular events in patients with peripheral arterial disease
    Skoglund, Per H.
    Ostergren, Jan
    Svensson, Per
    BLOOD PRESSURE, 2012, 21 (04) : 227 - 232
  • [16] Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: A prospective cohort study
    Saely, Christoph H.
    Schindewolf, Marc
    Zanolin, Daniela
    Heinzle, Christine F.
    Vonbank, Alexander
    Silbernagel, Guenther
    Leiherer, Andreas
    Drexel, Heinz
    Baumgartner, Iris
    ATHEROSCLEROSIS, 2018, 279 : 32 - 37
  • [17] Carotid Atherosclerotic Disease Predicts Cardiovascular Events in Hemodialysis Patients: A Prospective Study
    Collado, Slvia
    Coll, Elisabeth
    Nicolau, Carlos
    Pons, Mercedes
    Cruzado, Josep M.
    Pascual, Julio
    Cases, Aleix
    PLOS ONE, 2015, 10 (06):
  • [18] Factors Predicting Cardiovascular Events in Statin-Treated Diabetic and Non-Diabetic Coronary Patients: A Prospective Cohort Study
    Drexel, Heinz
    Greber, Susanne
    Gansch, Tobias
    Rein, Philipp
    Vonbank, Alexander
    Saely, Christoph H.
    CIRCULATION, 2010, 122 (21)
  • [19] Ultrasonic Evaluated Endothelial Dysfunction Highly Predicts Future Diabetic Evolution and Development of Fatal Events
    Murakami, Tatsuaki
    Misawa, Katsushi
    CIRCULATION, 2013, 128 (22)
  • [20] A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death
    Ikizler, T. Alp
    Parikh, Chirag R.
    Himmelfarb, Jonathan
    Chinchilli, Vernon M.
    Liu, Kathleen D.
    Coca, Steven G.
    Garg, Amit X.
    Hsu, Chi-yuan
    Siew, Edward D.
    Wurfel, Mark M.
    Ware, Lorraine B.
    Faulkner, Georgia Brown
    Tan, Thida C.
    Kaufman, James S.
    Kimmel, Paul L.
    Go, Alan S.
    KIDNEY INTERNATIONAL, 2021, 99 (02) : 456 - 465